Actively Recruiting
Serum Testosterone Level on Angiographic Complexity of Coronary Lesions in Premature Ischemic Egyptian Males
Led by Sohag University · Updated on 2025-07-22
50
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to investigate the association between serum testosterone levels and the angiographic complexity of coronary artery lesions in male patients under 45 years of age presenting with premature ischemic heart disease.
CONDITIONS
Official Title
Serum Testosterone Level on Angiographic Complexity of Coronary Lesions in Premature Ischemic Egyptian Males
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male patients aged <45 years
- Diagnosed with premature ischemic heart disease
- Undergoing elective coronary angiography for suspected coronary artery disease (CAD)
You will not qualify if you...
- History of acute coronary syndrome within the preceding 3 months
- Prior diagnosis of hypogonadism or history of testosterone replacement therapy or anabolic steroid use
- Active neoplasm or history of chemotherapy
- Known hepatic cirrhosis, chronic kidney disease, or end-stage renal disease
- Use of medications known to affect sex hormone levels (e.g., spironolactone, ketoconazole)
- Endocrine disorders such as sickle cell anemia or celiac disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sohag University
Sohag, Egypt, 82511
Actively Recruiting
Research Team
R
Remon S Adly, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here